New treatment approach for a type of epilepsy that affects children and young adults
Mechanistically-oriented therapy for a progressive myoclonus epilepsy
This study is looking at how changes in a specific gene might cause progressive myoclonus epilepsy type 7, which leads to tremors and seizures in kids and young adults, with the goal of finding new treatments to help improve their brain function and reduce symptoms.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Hosp of Philadelphia NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11047677 on NIH RePORTER |
What this research studies
This research focuses on progressive myoclonus epilepsy type 7 (EPM7), a severe condition that causes tremors, seizures, and ataxia in previously healthy children and young adults. The study aims to understand how genetic variations in the KCNC1 gene affect brain function and lead to EPM7. By investigating the role of Kv3.1 potassium channels, the researchers hope to develop targeted therapies that can restore normal function in affected neurons. This could potentially reduce seizures and improve motor function in patients with this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are children and young adults diagnosed with progressive myoclonus epilepsy type 7.
Not a fit: Patients with other forms of epilepsy or neurological disorders unrelated to the KCNC1 gene may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve the quality of life for patients with progressive myoclonus epilepsy.
How similar studies have performed: Other research has shown promise in targeting potassium channels for neurological conditions, suggesting that this approach may be effective.
Where this research is happening
Philadelphia, United States
- Children's Hosp of Philadelphia — Philadelphia, United States (Active)
Researchers
- Principal investigator: Goldberg, Ethan M — Children's Hosp of Philadelphia
- Study coordinator: Goldberg, Ethan M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.